Cervical cancer
- PMID: 30638582
- DOI: 10.1016/S0140-6736(18)32470-X
Cervical cancer
Abstract
Each year, more than half a million women are diagnosed with cervical cancer and the disease results in over 300 000 deaths worldwide. High-risk subtypes of the human papilloma virus (HPV) are the cause of the disease in most cases. The disease is largely preventable. Approximately 90% of cervical cancers occur in low-income and middle-income countries that lack organised screening and HPV vaccination programmes. In high-income countries, cervical cancer incidence and mortality have more than halved over the past 30 years since the introduction of formal screening programmes. Treatment depends on disease extent at diagnosis and locally available resources, and might involve radical hysterectomy or chemoradiation, or a combination of both. Conservative, fertility-preserving surgical procedures have become standard of care for women with low-risk, early-stage disease. Advances in radiotherapy technology, such as intensity-modulated radiotherapy, have resulted in less treatment-related toxicity for women with locally-advanced disease. For women with metastatic or recurrent disease, the overall prognosis remains poor; nevertheless, the incorporation of the anti-VEGF agent bevacizumab has been able to extend overall survival beyond 12 months. Preliminary results of novel immunotherapeutic approaches, similarly to other solid tumours, have shown promising results so far.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
Management of cervical precancers: a global perspective.Hematol Oncol Clin North Am. 2012 Feb;26(1):31-44. doi: 10.1016/j.hoc.2011.11.005. Epub 2011 Dec 14. Hematol Oncol Clin North Am. 2012. PMID: 22244660 Review.
-
Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.Vaccine. 2008 Aug 19;26 Suppl 12:M80-8. doi: 10.1016/j.vaccine.2008.05.041. Vaccine. 2008. PMID: 18945417
-
What school nurses need to know about cervical cancer, HPV, and the new vaccine.J Sch Nurs. 2007 Dec;23(6):310-4. doi: 10.1177/10598405070230060201. J Sch Nurs. 2007. PMID: 18052515 Review.
-
Screening and prevention: cervical cancer.Prim Care. 2009 Sep;36(3):559-74. doi: 10.1016/j.pop.2009.04.010. Prim Care. 2009. PMID: 19616155
-
Human papilloma viruses and cancer in the post-vaccine era.Clin Microbiol Infect. 2009 Nov;15(11):977-81. doi: 10.1111/j.1469-0691.2009.03032.x. Clin Microbiol Infect. 2009. PMID: 19874381 Review.
Cited by
-
Alternative splicing in the genome of HPV and its regulation.Front Cell Infect Microbiol. 2024 Oct 22;14:1443868. doi: 10.3389/fcimb.2024.1443868. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39502170 Free PMC article. Review.
-
Dual-Illumination Ultrasound/ Photoacoustic System for Cervical Cancer imaging.IEEE Photonics J. 2021 Feb;13(1):6900310. doi: 10.1109/jphot.2020.3043685. Epub 2020 Dec 14. IEEE Photonics J. 2021. PMID: 33828640 Free PMC article.
-
Association between breastfeeding and breast, thyroid, and cervical cancer among Korean adult women based on the Korean Genome and Epidemiology Study: a cohort study.Korean J Women Health Nurs. 2021 Dec 31;27(4):368-378. doi: 10.4069/kjwhn.2021.11.29. Epub 2021 Dec 13. Korean J Women Health Nurs. 2021. PMID: 36311452 Free PMC article.
-
Association of human papillomavirus 16 and 18 with ovarian cancer risk: Insights from a meta‑analysis.Oncol Lett. 2024 Sep 19;28(6):556. doi: 10.3892/ol.2024.14689. eCollection 2024 Dec. Oncol Lett. 2024. PMID: 39355783 Free PMC article.
-
Investigating the Underlying Mechanisms of Circular RNAs and Their Application in Clinical Research of Cervical Cancer.Front Genet. 2021 Mar 25;12:653051. doi: 10.3389/fgene.2021.653051. eCollection 2021. Front Genet. 2021. PMID: 33841509 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous